「ag」の検索結果
40件：16～20件目を表示
-
学会発表実績 | 研究開発活動 | 千寿製薬株式会社
Joint Meeting of Japan-Korea-China Ophthalmologists 開催日：2024年11月9日 開催地：コングレスクエア羽田 A Novel TRPV1 Antagonist, SJP-0132 for Dry Eye Disease – Results of a Randomized, Double-Masked, Placebo-Controlled P...
https://www.senju.co.jp/rd/society/ -
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
te that the information may differ from the up-to-date information depending on when it is updated. Agree Disagree Research & Development R & D activities R & D Pipeline Publications Meeti...
https://www.senju.co.jp/english/rd/trial.html -
製品開発方針 | 研究開発活動 | 千寿製薬株式会社
population. 2024. #4:横井則彦，加藤弘明：ドライアイ診療のパラダイムシフト 眼表面の層別診断・層別治療．京府医大誌, 2013 122(8) : 549-57 #5: Nakagawa T, Tokuda Y, Nakano M, Komori Y, Hanada N, Tourtas T, et al. RNA-Seq-based transcriptome analy...
https://www.senju.co.jp/rd/policy/ -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
Joint Meeting of Japan-Korea-China Ophthalmologists 開催日：2024年11月9日 開催地：コングレスクエア羽田 A Novel TRPV1 Antagonist, SJP-0132 for Dry Eye Disease – Results of a Randomized, Double-Masked, Placebo-Controlled P...
http://www.senju.co.jp/english/rd/society/ -
nding under the program Cyclic Innovation for Clinical Empowerment (CiCLE) established by the Japan Agency for Medical Research and Development (AMED). (1) Hayreh SS, and Zimmerman MB. Central retinal...
https://www.senju.co.jp/sites/default/files/content_news/2024-07/ENG_20240708_0.pdf